Safety of CGRP Inhibitors for Migraine

preview_player
Показать описание
Panelists review the favorable safety data for the recently approved monoclonal antibodies targeting calcitonin gene-related peptide (CGRP).
  1. NeurologyLive
Рекомендации по теме
Safety of CGRP 0:06:15

Safety of CGRP Inhibitors for Migraine

Efficacy and safety 0:01:24

Efficacy and safety of CGRP-directed antibodies in migraine

Migraine: Safety & 0:07:04

Migraine: Safety & Efficacy of Anti-CGRPs and Patient Selection

CGRP Inhibitors as 0:04:25

CGRP Inhibitors as Preventative Migraine Therapy

Latest guidelines on 0:02:24

Latest guidelines on anti-CGRP antibodies: first-line and long-term use

Real-world data suggests 0:04:34

Real-world data suggests that adding CGRP inhibitors to onabotulinumtoxinA adds efficacy

Christopher Gottschalk, MD: 0:01:56

Christopher Gottschalk, MD: Long-Term Safety in Preventive Migraine Therapies

Adverse Events of 0:22:19

Adverse Events of Anti-CGRP Monoclonal Antibodies for Migraine - Migraine MasterClass: Webinar 6

Real-world data on 0:08:29

Real-world data on anti-CGRP monoclonal antibodies

CGRP inhibitors and 0:10:01

CGRP inhibitors and everything you need to know. #gepants #CGRP #CGRPmAb

Microvascular complications of 0:03:00

Microvascular complications of CGRP antagonists for migraine patients with Raynaud’s phenomenon

Blocking CGRP in 0:02:09

Blocking CGRP in migraine patients: cardiovascular implications

Optimizing the Use 0:03:24

Optimizing the Use of CGRP Inhibitors in Migraine

Targeting CGRP for 0:02:04

Targeting CGRP for migraine prevention: the story so far

CGRP Inhibitors as 0:04:25

CGRP Inhibitors as Preventative Migraine Therapy

Ubrogepant safety by 0:01:06

Ubrogepant safety by age, gender and race

Safety of eptinezumab 0:01:34

Safety of eptinezumab in migraine patients

Unprecedented Efficacy of 0:07:36

Unprecedented Efficacy of CGRP Inhibitors for Migraine

Jessica Ailani, MD: 0:02:57

Jessica Ailani, MD: Long-Term Safety and Efficacy of Ubrogepant in Acute Migraine

The State of 0:06:12

The State of Monoclonal Antibodies for Migraine

Advantages of oral 0:14:28

Advantages of oral anti-CGRP drugs in migraine prevention

CGRP Inhibitors: Transformative 0:06:59

CGRP Inhibitors: Transformative Therapy for Migraine

Researchers Unveil Efficacy 0:02:03

Researchers Unveil Efficacy and Safety of New Migraine Drug

Lessons on the 0:12:05

Lessons on the side effects of CGRP antibodies in migraine

Комментарии
Автор

I think they better widen their study. Maybe check out the thousands of people reporting consistent side effects. I took this drug until I read about how important CGRP is in the body. I had very low energy, lost hair, nails became paper thin. I was lucky as these side effects are minimal to what has happened to others. Do your full research before taking. This is a dangerous drug

shopprealestateteam
Автор

I took Emgality, and ended up with a severe reaction. Sharp pain in my right leg, and extreme leg weakness, among other issues.
The didn't find a blood clot, so they're trying to figure out what's going on.

jedimasterham
Автор

The green screen was strong with this video

stephsoundsystem
Автор

to hear presentation some parts....close caption would be very helpful to appreciate this distinguished group of migraine experts.

edwconr